Soleno Therapeutics (SLNO) Share-based Compensation (2016 - 2019)
Historic Share-based Compensation for Soleno Therapeutics (SLNO) over the last 7 years, with Q4 2019 value amounting to $204000.0.
- Soleno Therapeutics' Share-based Compensation fell 6007.83% to $204000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $825000.0, marking a year-over-year decrease of 3653.85%. This contributed to the annual value of $100.0 million for FY2024, which is 158208.58% up from last year.
- Soleno Therapeutics' Share-based Compensation amounted to $204000.0 in Q4 2019, which was down 6007.83% from $153000.0 recorded in Q3 2019.
- In the past 5 years, Soleno Therapeutics' Share-based Compensation registered a high of $511000.0 during Q4 2018, and its lowest value of $136000.0 during Q1 2016.
- Its 5-year average for Share-based Compensation is $246882.0, with a median of $212000.0 in 2016.
- Per our database at Business Quant, Soleno Therapeutics' Share-based Compensation skyrocketed by 392000.0% in 2015 and then tumbled by 6608.48% in 2016.
- Soleno Therapeutics' Share-based Compensation (Quarter) stood at $196369.0 in 2015, then surged by 58.51% to $311270.0 in 2016, then crashed by 53.42% to $145000.0 in 2017, then skyrocketed by 252.41% to $511000.0 in 2018, then crashed by 60.08% to $204000.0 in 2019.
- Its last three reported values are $204000.0 in Q4 2019, $153000.0 for Q3 2019, and $220000.0 during Q2 2019.